Ligand Pharmaceuticals

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that assist pharmaceutical companies in discovering and developing drugs. We possess a diversified portfolio of biotechnology and pharmaceutical product revenue streams, supported by an efficient, low-cost corporate cost structure. Ligand’s Captisol® platform technology is a patented chemically modified cyclodextrin designed to optimize the solubility and stability of drugs. OmniAb® is a patented transgenic animal platform used for discovering fully human mono- and bispecific therapeutic antibodies.